RecruitingRecruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
NCT07185997 · ArriVent BioPharma, Inc.
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)
About this study
Global, Phase 3, randomized, multicenter, open-label study evaluating the efficacy and safety of firmonertinib at a dose level of 240 mg QD compared to investigator's choice of osimertinib (80 mg QD) or afatinib (40 mg QD) in participants who have locally advanced or metastatic NSCLC with EGFR PACC mutations, and who have not received any prior therapy for advanced disease. Participants will be randomized in a 1:1 ratio to treatment with firmonertinib or osimertinib or afatinib and will take the assigned dose daily.
Eligibility criteria
Key Eligibility Criteria:
* Histologically or cytologically documented, locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) not amenable to curative surgery or radiotherapy.
* Documented results of the presence of an Epidermal Growth Factor Receptor (EGFR) PACC mutation in tumor tissue or blood from local testing.
* No prior systemic anticancer therapy regimens received for locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) including prior treatment with any Epidermal Growth Factor Receptor (EGFR)-targeting agents (e.g., previous (EGFR) TKIs, monoclonal antibodies, or bispecific antibodies).
* Patients who have received prior neo-adjuvant and/or adjuvant chemotherapy, immunotherapy, or chemo radiotherapy for non-metastatic disease must have experienced a treatment free interval of at least 12 months.
* Patients with asymptomatic CNS metastases are eligible.
* List of eligible PACC mutations:
E709X, E709A, E709H, E709V, E709K E709\_T710delinsD, E709\_T710delinsA, E709\_T710delinsG, L718M, L718P, L718Q, L718V, G719X, G719A, G719C, G719D, G719S, G724S, E736K, I740\_K745dup, I740\_K745dupIPVAIK, I744\_K745insKIPVAI, L747P, L747S, K757M, K757R, V765L, S768I, S768\_V769delinsIL, S768\_V769delinsIM, S768\_V769delinsPL, V769L, V769M, N771G, H773\_V774delinsLM, V774M, R776C, R776H, G779F, L792H, G796S, T854A, T854S, T854I, A647T, R675W, S768C, A755D, A750\_I759delinsPN, T751\_I759delinsN
Study design
Enrollment target: 480 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2025-12-17
Estimated completion: 2030-12
Last updated: 2026-11-02
Interventions
Drug: FirmonertinibDrug: EGFR-TKI inhibitor based on investigator's choice
Primary outcomes
- • Progression Free Survival (PFS) determined by blinded independent central review (BICR) (Until progression or death, assessed up to approximately 4 years)
- • Confirmed overall response rate (ORR) as determined by BICR (Until progression or death, assessed up to approximately 3 years)
Sponsor
ArriVent BioPharma, Inc. · industry
Contacts & investigators
ContactClinical Trials · contact · FURMO006CT@arrivent.com · (888) 622-2827
InvestigatorJamuna Thimmarayappa · study_director, ArriVent BioPharm
All locations (141)
St. Jude Medical CenterRecruiting
Fullerton, California, United States
USC/Norris Comprehensive Cancer CenterRecruiting
Los Angeles, California, United States
Providence St. Joseph HospitalRecruiting
Orange, California, United States
University of California Davis Comprehensive Cancer CenterRecruiting
Sacramento, California, United States
UCSF Medical Center-Mission BayRecruiting
San Francisco, California, United States
Kaiser Permanente Medical CenterRecruiting
Vallejo, California, United States
University of Colorado HealthRecruiting
Aurora, Colorado, United States
Illinois Cancer SpecialistsRecruiting
Arlington Heights, Illinois, United States
University of Illinois Hospital and Health Sciences SystemsRecruiting
Chicago, Illinois, United States
Henry Ford Cancer InstituteRecruiting
Detroit, Michigan, United States
Northwell Health/R.J. Zuckerberg Cancer CenterRecruiting
Lake Success, New York, United States
Laura & Isaac Perlmutter Cancer Center at NYU Langone HealthRecruiting
New York, New York, United States
Columbia University Medical CenterRecruiting
New York, New York, United States
Ohio State University HospitalsRecruiting
Columbus, Ohio, United States
Fox Chase Cancer CenterRecruiting
Philadelphia, Pennsylvania, United States
Texas OncologyRecruiting
Dallas, Texas, United States
The University of Texas MD Anderson Cancer CenterRecruiting
Houston, Texas, United States
University of VirginiaRecruiting
Charlottesville, Virginia, United States
Virginia Cancer SpecialistsRecruiting
Fairfax, Virginia, United States
Shenandoah Oncology, P.C.Recruiting
Winchester, Virginia, United States
Swedish Cancer InstituteRecruiting
Edmonds, Washington, United States
Blacktown Cancer and Haematology CentreRecruiting
Blacktown, New South Wales, Australia
Chris O'Brien LifehouseRecruiting
Camperdown, New South Wales, Australia
GenesisCare North Shore Health HubRecruiting
St Leonards, New South Wales, Australia
Austin HealthRecruiting
Heidelberg, Victoria, Australia
Alberta Health Services, Tom Baker Cancer CentreRecruiting
Calgary, Alberta, Canada
University of Alberta - Cross Cancer Institute (CCI)Recruiting
Edmonton, Alberta, Canada
BC Cancer Vancouver CentreRecruiting
Vancouver, British Columbia, Canada
Brampton Civic Hospital, William Osler Health CentreRecruiting
Brampton, Ontario, Canada
The Ottawa Hospital Cancer CentreRecruiting
Ottawa, Ontario, Canada
Sunnybrook Research InstituteRecruiting
Toronto, Ontario, Canada
Princess Margaret Cancer Centre - University Health NetworkRecruiting
Toronto, Ontario, Canada
Anhui Provincial HospitalRecruiting
Hefei, Anhui, China
Cancer Hospital Chinese Academy of Medical SciencesRecruiting
Beijing, Beijing Municipality, China
Peking University People's HospitalRecruiting
Beijing, Beijing Municipality, China
Peking University Cancer Hospital (PKUCH)/Beijing Cancer HospitalRecruiting
Beijing, Beijing Municipality, China
Beijing Chest Hospital, Capital Medical UniversityRecruiting
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical UniversityRecruiting
Chongqing, Chongqing Municipality, China
Fujian Cancer HospitalRecruiting
Fuzhou, Fujian, China
Zhongshan Hospital Xiamen UniversityRecruiting
Xiamen, Fujian, China
The First People's Hospital of FoshanRecruiting
Foshan, Guangdong, China
The First Affiliated Hospital, Sun Yat-sen UniversityRecruiting
Guangzhou, Guangdong, China
Nanfang Hospital, Southern Medical UniversityRecruiting
Guangzhou, Guangdong, China
Cancer Hospital of Shantou University Medical CollegeRecruiting
Shantou, Guangdong, China
Guangxi Medical University Cancer HospitalRecruiting
Nanning, Guangxi, China
The Fourth Hospital of Hebei Medical UniversityRecruiting
Shijiazhuang, Hebei, China
Harbin Medical University Cancer HospitalRecruiting
Harbin, Heilongjiang, China
The First Affiliated Hospital of Henan University of Science & TechnologyRecruiting
Luoyang, Henan, China
The First Affiliated Hospital of Henan Medical UniversityRecruiting
Xinxiang, Henan, China
Henan Cancer CenterRecruiting
Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
Zhengzhou, Henan, China
Union Hospital Tongji Medical College Huazhong University Of Science And TechnologyRecruiting
Wuhan, Hubei, China
Xiangya Hospital of Central South UniversityRecruiting
Changsha, Hunan, China
Hunan Cancer HospitalRecruiting
Changsha, Hunan, China
Profile of The Third Xiangya Hospital of Central South UniversityRecruiting
Changsha, Hunan, China
The Affiliated Hospital of Inner Mongolia Medical UniversityRecruiting
Hohhot, Inner Mongolia, China
Jiangsu Province HospitalRecruiting
Nanjing, Jiangsu, China
Nanjing Drum Tower HospitalRecruiting
Nanjing, Jiangsu, China
Affiliated Hospital of Nantong UniversityRecruiting
Nantong, Jiangsu, China
The First Affiliated Hospital of Nanchang UniversityRecruiting
Nanchang, Jiangxi, China
The Second Hospital of Dalian Medical UniversityRecruiting
Dalian, Liaoning, China
The First Hospital of China Medical UniversityRecruiting
Shenyang, Liaoning, China
Cancer hospital of Dalian university of technologyRecruiting
Shenyang, Liaoning, China
China shenyang the tenth People's HospitalRecruiting
Shenyang, Liaoning, China
Jinan Central HospitalRecruiting
Jinan, Shandong, China
Linyi Cancer HospitalRecruiting
Linyi, Shandong, China
The Affiliated Hospital of Qingdao UniversityRecruiting
Qingdao, Shandong, China
Weifang People's HospitalRecruiting
Weifang, Shandong, China
Shanghai Geriatric Medical CenterRecruiting
Shanghai, Shanghai Municipality, China
Shanghai Chest HospitalRecruiting
Shanghai, Shanghai Municipality, China
Shanghai Pulmonary HospitalRecruiting
Shanghai, Shanghai Municipality, China
Shanxi Cancer HospitalRecruiting
Taiyuan, Shanxi, China
Sichuan Cancer HospitalRecruiting
Chengdu, Sichuan, China
West China Hospital of Sichuan UniversityRecruiting
Chengdu, Sichuan, China
Yibin Second People's HospitalRecruiting
Yibin, Sichuan, China
Tianjin Chest HospitalRecruiting
Tianjin, Tianjin Municipality, China
Tianjin Medical University Cancer Institute & HospitalRecruiting
Tianjin, Tianjin Municipality, China
Yunnan Cancer HospitalRecruiting
Kunming, Yunnan, China
The First Affiliated Hospital,Zhejiang University School of MedicineRecruiting
Hangzhou, Zhejiang, China
Zhejiang Cancer HospitalRecruiting
Hangzhou, Zhejiang, China
Hospices Civil de LyonRecruiting
Bron, Auvergne-Rhône-Alpes, France
Hospital Nord de MarseilleRecruiting
Marseille, Bouches-du-Rhone, France
Centre Francois BaclesseRecruiting
Caen, Calvados, France
Hopital LarreyRecruiting
Toulouse, Occitanie, France
Centre Leon-BerardRecruiting
Lyon, France
Hopital Nord Guilaume-et-Rene-Laennec CHU de NantesRecruiting
Saint-Herblain, France
Insitut de Canderologie d I'OuestRecruiting
Saint-Herblain, France
Henry Dunant Hospital CenterRecruiting
Athens, Greece
University General Hospital Attikon - General Hospital of West Attica H AGIA VARVARARecruiting
Athens, Greece
Athens Medical Center S.A., European Interbalkan Medical CenterRecruiting
Thessaloniki, Greece
Thoracic General Hospital of Athens I SotiriaRecruiting
Thessaloniki, Greece
Queen Mary HospitalRecruiting
Hong Kong, Hong Kong, Hong Kong
Prince of Wales HospitalRecruiting
Shatin, New Territories, Hong Kong
Humanity and Health Clinical Trial CentreRecruiting
Central, Hong Kong
SOC Oncologia Medica e dei Tumori Immuno-correlatiRecruiting
Aviano, Italy
Istituto Europeo di Oncologia (IEO)Recruiting
Milan, Italy
Aichi Cancer CenterRecruiting
Nagoya, Aichi-ken, Japan
Fujita Health University HospitalRecruiting
Toyoake, Aichi-ken, Japan
National Cancer Center Hospital EastRecruiting
Kashiwa, Chiba, Japan
Kurume University HospitalRecruiting
Kurume-Shi, Fukuoka, Japan
National Hospital Organization Hokkaido Cancer CenterRecruiting
Sapporo, Hokkaido, Japan
Hyogo Cancer CenterRecruiting
Akashi-shi, Hyōgo, Japan
Miyagi Cancer CenterRecruiting
Natori-shi, Miyagi, Japan
Niigata Cancer Center HospitalRecruiting
Niigata, Niigata, Japan
Kansai Medical University HospitalRecruiting
Hirakata-shi, Osaka, Japan
Nippon Medical School HospitalRecruiting
Bunkyo-ku, Tokyo, Japan
Tokyo Metropolitan Komagome HospitalRecruiting
Bunkyō-Ku, Tokyo, Japan
National Cancer Center HospitalRecruiting
Chuo-ku, Tokyo, Japan
OncoCar Cancer CentreRecruiting
Petaling Jaya, Selangor, Malaysia
Hospital Kuala LumpurRecruiting
Kuala Lumpur, WP Kuala Lumpur, Malaysia
National Cancer Centre SingaporeRecruiting
Singapore, Singapore
Curie Oncology (Farrer)Recruiting
Singapore, Singapore
Tan Tok Seng HospitalRecruiting
Singapore, Singapore
The Catholic University of Korea, St. Vincent's HospitalRecruiting
Suwon, Gyeonggi-do, South Korea
Chonnam National University Hwasun HospitalRecruiting
Hwasun, Jeollanam-do, South Korea
Gachon University Gil Medical CenterRecruiting
Incheon, South Korea
Kyung Hee University HospitalRecruiting
Seoul, South Korea
Kangbuk Samsung HospitalRecruiting
Seoul, South Korea
Asan Medical CenterRecruiting
Seoul, South Korea
Samsung Medical CenterRecruiting
Seoul, South Korea
Hospital Universitari Son EspasesRecruiting
Palma, Balearic Islands, Spain
Hospital Clinic de BarcelonaRecruiting
Barcelona, Spain
Hospital QuironSalud MalagaRecruiting
Málaga, Spain
Hospital Universitario Central de AsturiasRecruiting
Oviedo, Spain
Hospital Universitario y Politecnico La FeRecruiting
Valencia, Spain
Kaohsiung Medical University Chung-Ho Memorial HospitalRecruiting
Kaohsiung City, Taiwan
Taichung Veterans General HospitalRecruiting
Taichung, Taiwan
National Taiwan University Cancer CenterRecruiting
Taipei, Taiwan
Taipei Veterans General HospitalRecruiting
Taipei, Taiwan
Mahidol University - Siriraj HospitalRecruiting
Bangkoknoi, Bangkok, Thailand
Chulabhorn HospitalRecruiting
Lak Si, Bangkok, Thailand
Prince of Songkla HospitalRecruiting
Hat Yai, Changwat Songkhla, Thailand
Faculty of Medicine Vajira Hospital, Navamindradhiraj UniversityRecruiting
Bangkok, Thailand
Memorial Ankara HospitalRecruiting
Ankara, Ankara, Turkey (Türkiye)
Gulhane Training and Research HospitalRecruiting
Ankara, Turkey (Türkiye)
Anatalya ProvinceRecruiting
Antalya, Turkey (Türkiye)
Medical Park Florya HospitalRecruiting
Istanbul, Turkey (Türkiye)
Istinye University Bahcesehir Liv HospitalRecruiting
Istanbul, Turkey (Türkiye)
University College London Hospitals NHS Foundation TrustRecruiting
London, England, United Kingdom
The Christie NHS Foundation TrustRecruiting
Manchester, England, United Kingdom
The Royal Marsden NHS Foundation TrustRecruiting
London, United Kingdom